A pharmacological approach in newly established retinal vein occlusion model

The mechanism underlying the effects of anti-vascular endothelial growth factor (VEGF) antibody in retinal vein occlusion (RVO) treatment is poorly understood, partly due to the lack of RVO animal models that mimic clinical pathology. The aims of this study were to establish a suitable RVO model, cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuma, Shinichiro, Nishinaka, Anri, Inoue, Yuki, Tsuruma, Kazuhiro, Shimazawa, Masamitsu, Kondo, Mineo, Hara, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333144/
https://www.ncbi.nlm.nih.gov/pubmed/28252108
http://dx.doi.org/10.1038/srep43509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333144/
https://www.ncbi.nlm.nih.gov/pubmed/28252108
http://dx.doi.org/10.1038/srep43509

Ejemplares similares